| Literature DB >> 29805223 |
N J Chaudhary1, D M Patel1, A J Dhami1, K B Vala2, K K Hadiya1, J A Patel1.
Abstract
AIM: This study aimed to evaluate the efficacy of Doublesynch and Estradoublesynch protocols on estrus induction, conception rates, plasma progesterone, protein, and cholesterol profile in anestrus Gir heifers.Entities:
Keywords: Gir heifers; cholesterol; conception rate; estrus synchronization; progesterone; proteins; pubertal anestrus
Year: 2018 PMID: 29805223 PMCID: PMC5960797 DOI: 10.14202/vetworld.2018.542-548
Source DB: PubMed Journal: Vet World ISSN: 0972-8988
Effect of Doublesynch and Estradoublesynch protocols on estrus induction response, estrus induction intervals, and conception rates in pubertal anestrus Gir heifers.
| Treatment groups | No. | Estrus induction response (%) | PGF2a injection to estrus induction interval (h) | Conception rate (%) | Status of NP Gir heifers at 60-day post-AI | Initiation of treatment to conception (days) | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Induced/first estrus | Second cycle | Third cycle | Overall of 3 cycles | Cyclic | Anestrus | |||||
| Doublesynch | 20 | 85.00 (n=17) | 63.87±4.19 | 20.00 (4/20) | 23.07 (3/13) | 22.22 (2/9) | 45.00 (9/20) | 7 | 4 | 27.89±5.75 |
| Estradoublesych | 20 | 95.00 (n=19) | 58.27±3.83 | 30.00 (6/20) | 16.66 (2/12) | 30.00 (3/10) | 55.00 (11/20) | 6 | 3 | 26.45±5.48 |
| Anestrus control | 10 | 20.00 (n=2) | - | 50.00 (1/2) | 0.00 (0/1) | 00.00 (0/1) | 10.00 (1/10) | 1 | 8 | 83.00 |
NP=Nonpregnant, PGF2a: Prostaglandin F2a.
From the initiation of the experiment. Statistically, the values were similar between protocols
Plasma progesterone, total protein, and total cholesterol concentrations in pubertal anestrus Gir heifers on different days of various estrus induction/synchronization protocols and day 12 post-AI.
| Plasma profile | Synchronization protocol | Status | No. of heifers | Days from treatment/AI | ||||
|---|---|---|---|---|---|---|---|---|
| D0 | D9 | D12, FTAI | D12 post-AI | Overall | ||||
| Progesterone (ng/ml) | Doublesynch | Conceived | 4 | 0.72±0.08 | 1.80±0.31q | 0.48±0.02 | 5.30±0.56q | 2.08±0.52q |
| Non-concd | 16 | 0.53±0.06 | 1.09±0.11p | 0.56±0.05 | 1.69±0.21p | 0.96±0.08p | ||
| Overall | 20 | 0.56±0.05x | 1.23±0.12y | 0.54±0.04x | 2.41±0.38z | 1.19±0.13 | ||
| Estradoublesynch | Conceived | 6 | 0.44±0.04 | 2.46±0.40q | 0.53±0.05 | 5.02±0.49q | 2.11±0.42q | |
| Non-concd | 14 | 0.58±0.05 | 0.95±0.07p | 0.54±0.05 | 1.49±0.17p | 0.89±0.07p | ||
| Overall | 20 | 0.54±0.04x | 1.40±0.20y | 0.53±0.04x | 2.55±0.41z | 1.25±0.15 | ||
| Protein (g/dl) | Doublesynch | Conceived | 4 | 7.20±0.09 | 7.27±0.10 | 7.32±0.12 | 7.25±0.12 | 7.26±0.05 |
| Non-concd | 16 | 7.02±0.24 | 7.27±0.27 | 7.28±0.22 | 7.25±0.22 | 7.21±0.12 | ||
| Overall | 20 | 7.06±0.19 | 7.27±0.21 | 7.29±0.18a | 7.26±0.18a | 7.22±0.09a | ||
| Estradoublesynch | Conceived | 6 | 7.41±0.26 | 7.47±0.25 | 7.85±0.20 | 8.09±0.28 | 7.70±0.13 | |
| Non-concd | 14 | 7.17±0.20 | 7.44±0.18 | 7.72±0.17 | 7.76±0.16 | 7.52±0.09 | ||
| Overall | 20 | 7.24±0.16x | 7.45±0.14×y | 7.76±0.13by | 7.86±0.14by | 7.58±0.07b | ||
| Cholesterol (mg/dl) | Doublesynch | Conceived | 4 | 117.88±8.56 | 120.10±7.40 | 137.6850±6.08 | 142.98±10.31 | 129.67±4.63p |
| Non-concd | 16 | 127.45±3.68 | 134.83±3.33 | 145.8113±4.23 | 149.97±3.92 | 139.51±2.17q | ||
| Overall | 20 | 125.53±3.41x | 131.88±3.25ax | 144.19±3.61y | 148.58±3.68y | 137.54±2.00a | ||
| Estradoublesynch | Conceived | 6 | 120.88±4.41p | 131.75±3.79p | 143.79±2.34p | 137.41±1.24p | 133.46±2.30p | |
| Non-concd | 14 | 134.40±3.17q | 147.47±3.54q | 158.84±4.57q | 160.88±4.91q | 150.39±2.45q | ||
| Overall | 20 | 130.34±2.89x | 142.76±3.14by | 154.32±3.60z | 153.83±4.21z | 145.32±2.03b | ||
D-0=Day of starting the treatment, D-9=Day of PG injection, While D-12=Fixedtimed artificial insemination, Non-concd=Non-conceived. Means of a trait bearing uncomon superscripts within the row (x, y, z), column (a, b), and conceived and nonconceived (p, q) subgroups within the protocol differ significantly (p<0.05). FTAI=Fixed-timed artificial insemination